SynthesisBMC cancer2024

Efficacy of neoadjuvant PD-1/PD-L1 inhibitor in resectable NSCLC: a meta-analysis based on randomized controlled trials.

Weiming Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.